Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2
List of Figures 8
2 Introduction 9
2.1 What Is This Report About?
9
3 Definitions of Markets Covered in the Report 10
3.1 Diabetes Care
Devices 10
3.2 Glucose Monitoring Devices 10
3.3 Insulin Delivery
10
4 Diabetes Care Devices in North America 11
4.1 Diabetes Care
Devices, North America, Overall Revenue ($ mn), 2000-2015 11
4.2 Diabetes
Care Devices, North America, Category Volume (Units), 2000-2015 15
4.3
Diabetes Care Devices, North America, Company share (2007-2008) 18
5
Diabetes Care Devices In United States 19
5.1 Diabetes Care Devices,
United States, Overall Revenue ($ mn), 2000-2015 19
5.2 Diabetes Care
Devices, United States, Category Volume (Units), 2000-2015 22
5.3 Diabetes
Care Devices, United States, Distribution Share (2007-2008) 25
5.3.1
Glucose Monitoring Distribution Share (2007-2008) 25
5.3.2 Insulin
Delivery Distribution Share (2007-2008) 25
5.4 Diabetes Care Devices,
United States, Company Share (2007-2008) 26
5.4.1 Diabetes Care Devices,
United States, Company Share (2007-2008) 26
5.4.2 Glucose Monitoring,
United States, Company Share (2007-2008) 27
5.4.3 Insulin Delivery, United
States, Company Share (2007-2008) 28
6 Diabetes Care Devices In Canada
29
6.1 Diabetes Care Devices, Canada, Overall Revenue ($ mn), 2000-2015
29
6.2 Diabetes Care Devices, Canada, Category Volume (Units), 2000-2015
32
6.3 Diabetes Care Devices, Canada, Distribution Share (2007-2008)
35
6.3.1 Glucose Monitoring Distribution Share (2007-2008) 35
6.3.2
Insulin Delivery Distribution Share (2007-2008) 35
6.4 Diabetes Care
Devices, Canada, Company Share (2007-2008) 36
6.4.1 Diabetes Care Devices,
Canada, Company Share (2007-2008) 36
6.4.2 Glucose Monitoring, Canada,
Company Share (2007-2008) 37
6.4.3 Insulin Delivery, Canada, Company Share
(2007-2008) 38
7 Overview of Key Companies in Brazil Diabetes Care Devices
Market 39
7.1 LifeScan, Inc. 39
7.1.1 Company Overview 39
7.1.2
LifeScan, Inc. Pipeline Products 39
7.2 F. Hoffmann-La Roche Ltd. 40
7.2.1 Company Overview 40
7.2.2 Value Chain Analysis 41
7.2.3 F.
Hoffmann-La Roche Ltd Pipeline Products 43
7.3 Bayer HealthCare AG 44
7.3.1 Company Overview 44
7.3.2 Value Chain Analysis 45
7.3.3 Bayer
HealthCare AG Pipeline Products 47
7.4 Abbott Laboratories 48
7.4.1
Company Overview 48
7.4.2 Value Chain Analysis 49
7.4.3 Abbott
Laboratories Pipeline Products 51
7.5 Becton, Dickinson and Company 53
7.5.1 Company Overview 53
7.5.2 Value Chain Analysis 53
7.6 Medtronic,
Inc. 55
7.6.1 Company Overview 55
7.6.2 Value Chain Analysis 56
7.6.3 Medtronic, Inc. Pipeline Products 58
7.7 Terumo Corporation 66
7.7.1 Company Overview 66
7.7.2 Value Chain Analysis 66
7.8 Eli Lilly
and Company 69
7.8.1 Company Overview 69
7.8.2 Value Chain Analysis
69
7.8.3 Eli Lilly and Company Pipeline Products 72
7.9 ARKRAY, Inc.
73
7.9.1 Company Overview 73
7.9.2 ARKRAY, Inc. Pipeline Products
73
7.10 Novo Nordisk A/S 75
7.10.1 Company Overview 75
7.10.2 Novo
Nordisk A/S Pipeline Products 75
7.11 Animas Corporation 76
7.11.1
Company Overview 76
7.12 Sanofi-Aventis 76
7.12.1 Company Overview
76
7.13 Smiths Medical 77
7.13.1 Company Overview 77
7.13.2 Value
Chain Analysis 78
7.14 Apex Biotechnology Corp. 80
7.14.1 Company
Overview 80
7.15 Panasonic Corporation 80
7.15.1 Company Overview
80
8 Recent Developments 81
8.1 Strategy and Business Planning 81
8.1.1 May 22, 2009: DDI Plans To Add 100 Employees 81
8.1.2 May 21, 2009:
Eli Lilly Launches Two Global Trials for Alzheimer' Disease 81
8.1.3 May
11, 2009: Medtronic Announces San Antonio as Home of New Diabetes Facility
81
8.1.4 Mar 25, 2009: Medtronic Leases Nearly 50,000 Square-Foot Facility
for Ablation Frontiers Unit 83
8.1.5 Mar 10, 2009: Medtronic MiniMed
Considers San Antonio and Kansas City For Expansion 83
8.2 Legal and
Regulatory 85
8.2.1 Mar 11, 2009: Medtronic Announces Dismissal Of Lawsuit
85
8.3 Government and Public Interest 85
8.3.1 May 19, 2009: Piramal
Launches Trial Material Packaging Capacity In UK 85
8.3.2 Mar 19, 2009:
FDA: Insulin Pens and Insulin Cartridges Must Not Be Shared 85
8.4 Product
News 86
8.4.1 Jun 02, 2009: Bayer Diabetes Care Announces the Launch of
A1CNow SELFCHECK 86
8.4.2 May 05, 2009: Bayer HealthCare Releases CONTOUR
Meters In Two Bold New Colors, the Midnight Blue and Orange Burst 87
8.4.3
Apr 30, 2009: Disetronic Medical Systems Inc Announces Recall of the ACCU-CHEK
Spirit Insulin Pump Due To Potential Button Failure 87
8.4.4 Apr 27, 2009:
TREE2go Receives Medical Design Excellence Award 88
8.4.5 Apr 20, 2009:
Sanofi-Aventis Announces US Availability of Apidra SoloSTAR 88
8.4.6 Apr
14, 2009: Entra Health Launches FDA Cleared Bluetooth-Enabled Blood Glucose
Meter in US 88
8.4.7 Mar 25, 2009: Smiths Medical Announces Intent to Stop
Selling Deltec Cozmo Insulin Pumps 89
8.4.8 Feb 26, 2009: FDA Approves
Sanofi-aventis' Apidra SoloSTAR 90
8.4.9 Feb 11, 2009: Insulet
Corporation' s OmniPod System Selected As Finalist For The 2009 Edison Best New
Product Awards 90
8.4.10 Feb 09, 2009: ARKRAY Announces FDA Approval To
Market GLUCOCARD 01-mini Blood Glucose Monitoring System 90
8.4.11 Dec 23,
2008: Generex Receives Approval For Oral-lyn 91
9 Appendix 92
9.1
Global Markets Direct Research Methodology 92
9.2 Coverage 93
9.3
Secondary Research 93
9.4 Primary Research 94
9.5 Models 94
9.6
Forecasts 95
9.7 Expert Panel Validation 95
9.8 Currency Conversion
96
9.9 Contact Us 97
9.10 Disclaimer 97
1.1 List of
Tables
Table 1: Diabetes Care Devices, North America, Overall Revenue
($ mn), 2000-2015 11
Table 2: Diabetes Care Devices, North America,
Cross-Category Analysis, 2000-2015 12
Table 3: Diabetes Care Devices,
North America, Overall Revenue ($ mn), Historic, 2000-2008 13
Table 4:
Diabetes Care Devices, North America, Overall Revenue ($ mn), Forecast,
2008-2015 14
Table 5: Diabetes Care Devices, North America, Category
Volume (Units), 2000-2015 15
Table 6: Diabetes Care Devices, North
America, Category Volume (Units), Historic, 2000-2008 16
Table 7:
Diabetes Care Devices, North America, Category Volume (Units), Forecast,
2008-2015 17
Table 8: Diabetes Care Devices, North America, Company
share by Revenue ($ mn), 2007-2008 18
Table 9: Diabetes Care Devices,
United States, Overall Revenue ($ mn), 2000-2015 19
Table 10:
Diabetes Care Devices, United States, Overall Revenue ($ mn), Historic,
2000-2008 20
Table 11: Diabetes Care Devices, United States, Overall
Revenue ($ mn), Forecast, 2008-2015 21
Table 12: Diabetes Care
Devices, United States, Category Volume (Units), 2000-2015 22
Table 13:
Diabetes Care Devices, United States, Category Volume (Units), Historic,
2000-2008 23
Table 14: Diabetes Care Devices, United States, Category
Volume (Units), Forecast, 2008-2015 24
Table 15: Glucose Monitoring,
United States, Distribution Share by Revenue ($mn), 2007-2008 25
Table 16:
Insulin Delivery, United States, Distribution Share by Revenue ($mn),
2007-2008 25
Table 17: Diabetes Care Devices, United States, Company
Share by Revenue ($ mn), 2007-2008 26
Table 18: Glucose Monitoring,
United States, Company Share by Revenue ($ mn), 2007-2008 27
Table 19:
Insulin Delivery, United States, Company Share by Revenue ($ mn), 2007-2008
28
Table 20: Diabetes Care Devices, Canada, Overall Revenue ($ mn),
2000-2015 29
Table 21: Diabetes Care Devices, Canada, Overall Revenue
($ mn), Historic, 2000-2008 30
Table 22: Diabetes Care Devices,
Canada, Overall Revenue ($ mn), Forecast, 2008-2015 31
Table 23:
Diabetes Care Devices, Canada, Category Volume (Units), 2000-2015 32
Table
24: Diabetes Care Devices, Canada, Category Volume (Units), Historic,
2000-2008 33
Table 25: Diabetes Care Devices, Canada, Category Volume
(Units), Forecast, 2008-2015 34
Table 26: Glucose Monitoring, Canada,
Distribution Share by Revenue ($mn), 2007-2008 35
Table 27: Insulin
Delivery, Canada, Distribution Share by Revenue ($mn), 2007-2008 35
Table
28: Diabetes Care Devices, Canada, Company Share by Revenue ($ mn),
2007-2008 36
Table 29: Glucose Monitoring, Canada, Company Share by
Revenue ($ mn), 2007-2008 37
Table 30: Insulin Delivery, Canada,
Company Share by Revenue ($ mn), 2007-2008 38
Table 31: LifeScan,
Inc. Pipeline Products by Equipment Type 39
Table 32: LifeScan, Inc.
Pipeline Products by Development Stage 39
Table 33: LifeScan, Inc.
Pipeline Products by Therapy Area 39
Table 34: LifeScan, Inc.
Pipeline Products by Clinical Trials 40
Table 35: LifeScan, Inc.
Pipeline Products by News Summary 40
Table 36: F. Hoffmann-La Roche
Ltd Pipeline Products by Equipment Type 43
Table 37: F. Hoffmann-La
Roche Ltd Pipeline Products by Development Stage 43
Table 38: F.
Hoffmann-La Roche Ltd Pipeline Products by Therapy Area 43
Table 39:
Bayer HealthCare AG Pipeline Products by Equipment Type 47
Table 40:
Bayer HealthCare AG Pipeline Products by Development Stage 47
Table 41:
Bayer HealthCare AG Pipeline Products by Therapy Area 47
Table 42:
Bayer HealthCare AG Pipeline Products by News Summary 47
Table 43:
Abbott Laboratories Pipeline Products by Equipment Type 51
Table 44:
Abbott Laboratories Pipeline Products by Development Stage 51
Table 45:
Abbott Laboratories Pipeline Products by Therapy Area 51
Table 46:
Abbott Laboratories Pipeline Products by Clinical Trials 52
Table 47:
Abbott Laboratories Pipeline Products by News Summary 52
Table 48:
Medtronic, Inc. Pipeline Products by Equipment Type 58
Table 49:
Medtronic, Inc. Pipeline Products By Development Stage 60
Table 50:
Medtronic, Inc. Pipeline Products By Therapy Area 62
Table 51:
Medtronic, Inc. Pipeline Products By Clinical Trials 64
Table 52:
Medtronic, Inc. Pipeline Products By News Summary 65
Table 53: Eli
Lilly and Company Pipeline Products by Equipment Type 72
Table 54:
Eli Lilly and Company Pipeline Products by Development Stage 72
Table 55:
Eli Lilly and Company Pipeline Products by Therapy Area 72
Table 56:
Eli Lilly and Company Pipeline Products by Clinical Trials 72
Table 57:
Eli Lilly and Company Pipeline Products by News Summary 72
Table 58:
ARKRAY, Inc. Pipeline Products by Equipment Type 73
Table 59:
ARKRAY, Inc. Pipeline Products by Development Stage 73
Table 60:
ARKRAY, Inc. Pipeline Products by Clinical Trials 74
Table 61:
ARKRAY, Inc. Pipeline Products by News Summary 74
Table 62: Novo
Nordisk A/S Pipeline Products by Equipment Type 75
Table 63: Novo
Nordisk A/S Pipeline Products By Development Stage 75
Table 64: Novo
Nordisk A/S Pipeline Products By Therapy Area 76
Table 65: Novo
Nordisk A/S Pipeline Products By Clinical Trials 76
Table 66: USD to
Local Currency, Average Exchange Rate 2008 96
1.2 List of
Figures
Figure 1: Diabetes Care Devices, North America, Overall
Revenue ($ mn), 2000-2015 11
Figure 2: Diabetes Care Devices, North
America, Cross-Category Analysis, 2000-2015 12
Figure 3: Diabetes
Care Devices, North America, Overall Revenue ($ mn), Historic, 2000-2008
13
Figure 4: Diabetes Care Devices, North America, Overall Revenue ($
mn), Forecast, 2008-2015 14
Figure 5: Diabetes Care Devices, North
America, Category Volume (Units), 2000-2015 15
Figure 6: Diabetes
Care Devices, North America, Category Volume (Units), Historic, 2000-2008
16
Figure 7: Diabetes Care Devices, North America, Category Volume
(Units), Forecast, 2008-2015 17
Figure 8: Diabetes Care Devices,
North America, Company share (%), 2008 18
Figure 9: Diabetes Care
Devices, United States, Overall Revenue ($ mn), 2000-2015 19
Figure 10:
Diabetes Care Devices, United States, Overall Revenue ($ mn), Historic,
2000-2008 20
Figure 11: Diabetes Care Devices, United States, Overall
Revenue ($ mn), Forecast, 2008-2015 21
Figure 12: Diabetes Care
Devices, United States, Category Volume (Units), 2000-2015 22
Figure 13:
Diabetes Care Devices, United States, Category Volume (Units), Historic,
2000-2008 23
Figure 14: Diabetes Care Devices, United States,
Category Volume (Units), Forecast, 2008-2015 24
Figure 15: Diabetes
Care Devices, United States, Company Share (%), 2008 26
Figure 16:
Glucose Monitoring, United States, Company Share (%), 2008 27
Figure 17:
Insulin Delivery, United States, Company Share (%), 2008 28
Figure 18:
Diabetes Care Devices, Canada, Overall Revenue ($ mn), 2000-2015 29
Figure 19: Diabetes Care Devices, Canada, Overall Revenue ($ mn),
Historic, 2000-2008 30
Figure 20: Diabetes Care Devices, Canada,
Overall Revenue ($ mn), Forecast, 2008-2015 31
Figure 21: Diabetes
Care Devices, Canada, Category Volume (Units), 2000-2015 32
Figure 22:
Diabetes Care Devices, Canada, Category Volume (Units), Historic, 2000-2008
33
Figure 23: Diabetes Care Devices, Canada, Category Volume (Units),
Forecast, 2008-2015 34
Figure 24: Diabetes Care Devices, Canada,
Company Share (%), 2008 36
Figure 25: Glucose Monitoring, Canada,
Company Share (%), 2008 37
Figure 26: Insulin Delivery, Canada,
Company Share (%), 2008 38
Figure 27: F. Hoffmann-La Roche Ltd Value
Chain Analysis 41
Figure 28: Bayer HealthCare AG Value Chain Analysis
45
Figure 29: Abbott Laboratories Value Chain Analysis 49
Figure
30: Becton, Dickinson and Company Value Chain Analysis 53
Figure 31:
Medtronic, Inc. Value Chain Analysis 56
Figure 32: Terumo
Corporation Value Chain Analysis 66
Figure 33: Eli Lilly and Company
Value Chain Analysis 69
Figure 34: Smiths Medical Value Chain
Analysis 78
Figure 35: Global Markets Direct Methodology 92
|
Related Report
|
View Cart
